Showing results (161-170 of 736) with videos related to
Sort By:
Pageof 74
Clinical Pharmacology and Therapeutics|April 5, 2008
Genetic influences in the variation in renal clearance of nicotine and cotinineN L Benowitz, C N Lessov-Schlaggar, G E SwanBritish Journal of Clinical Pharmacology|March 9, 2005
Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjectsC Csajka, C A Haller, N L Benowitz, et al.Current Opinion in Pulmonary Medicine|July 17, 1999
Environmental tobacco smoke and lung cancer incidenceC T Leonard, D P SachsClinics in Chest Medicine|December 1, 1991
Pharmacologic approaches to smoking cessationD P Sachs, S J LeischowClinical Pharmacology and Therapeutics|January 1, 1993
Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effectsJ Shi, N L Benowitz, C P Denaro, et al.American Journal of Public Health|June 1, 1988
Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposureM J Jarvis, M A Russell, N L Benowitz, et al.European Journal of Clinical Pharmacology|January 1, 1997
Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatmentS G Gourlay, N L Benowitz, A Forbes, et al.Archives of General Psychiatry|April 1, 1990
Nicotine exposure among nondependent smokersS Shiffman, L B Fischer, M Zettler-Segal, et al.Clinical Pharmacology and Therapeutics|July 1, 1987
Prolonged absorption with development of tolerance to toxic effects after cutaneous exposure to nicotineN L Benowitz, T Lake, K H Keller, et al.Pharmacology, Biochemistry, and Behavior|April 1, 1988
Nicotine gum: chew rate, subjective effects and plasma nicotineR Nemeth-Coslett, N L Benowitz, N Robinson, et al.Pageof 74